<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00136838</url>
  </required_header>
  <id_info>
    <org_study_id>#4725(2)</org_study_id>
    <secondary_id>R01DA017572</secondary_id>
    <secondary_id>R01DA017572-02</secondary_id>
    <secondary_id>DPMC</secondary_id>
    <nct_id>NCT00136838</nct_id>
  </id_info>
  <brief_title>Effect of Smoking Exposure on Smoking Relapse Following Brief Abstinence - 2</brief_title>
  <official_title>Effect of Smoking Exposure on Tobacco Self-Administration Following Brief Abstinence</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>New York State Psychiatric Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Drug Abuse (NIDA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>New York State Psychiatric Institute</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Recent research on the effects of nicotine on the brain and behavior presents an opportunity
      to advance medication development.

      The purpose of this study is to develop a laboratory model for early-stage testing of new and
      existing treatments for nicotine addiction. Specifically, the investigators will develop a
      laboratory model of relapse to cigarette use in nicotine dependent volunteers.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Tobacco use is the leading preventable cause of death in the United States. Recent research
      on the effects of nicotine on the brain and behavior presents an opportunity to advance
      medication development. The goal of this study is to develop a laboratory model for
      early-stage testing of new and existing compounds for the treatment of tobacco and nicotine
      addiction. In addition, the objective of this study is to develop a laboratory model of
      relapse induced by cigarette exposure that would reproduce the psychological and
      physiological processes that are involved when abstinent individuals progress from initial
      cigarette smoking (lapse) to a pre-abstinence level of use (relapse). Such a model may be
      used to study the mechanisms of relapse and to screen medications that might be effective in
      preventing relapse in treatment seekers.

      This study will consist of two phases. Each phase will consist of a 5-day inpatient stay.
      During the first portion of inpatient stay, participants will not be permitted to smoke.
      During the second portion of inpatient stay, smoking reinstatement will be modeled, as
      participant will have opportunity to smoke, following the exposure to tobacco-related or
      control cues. A variety of behavioral, subjective, physiological, and performance measures
      will be assessed throughout the study.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2001</start_date>
  <completion_date type="Actual">June 2006</completion_date>
  <primary_completion_date type="Actual">June 2006</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cigarette Choice After 3 Day Abstinence</measure>
    <time_frame>During Day 4 experimental session</time_frame>
    <description>Following 3 days of abstinence participants had an option to smoke cigarettes every 30 minutes for the maximum of 6 choices</description>
  </primary_outcome>
  <other_outcome>
    <measure>Craving</measure>
    <time_frame>immediately following cue expose</time_frame>
    <description>Measure of self-reported craving on a scale of 0-70 (0=no craving; 70= worst possible craving).</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">12</enrollment>
  <condition>Tobacco Use Disorder</condition>
  <arm_group>
    <arm_group_label>Neutral Cue first, then Active Cue</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Each participant receives two consecutive interventions.
Neutral Cue: during this phase of treatment participants were presented with neutral (sham) cue
Cigarette cue: during this phase of treatment participants were presented with active cigarette cue.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Active Cue first, then Neutral Cue</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Each participant receives two consecutive interventions.
Cigarette cue: during this phase of treatment participants were presented with active cigarette cue.
Neutral Cue: during this phase of treatment participants were presented with neutral (sham) cue</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Neutral or active cigarette cues</intervention_name>
    <description>Packets of cigarettes or cigarette smoke.</description>
    <arm_group_label>Neutral Cue first, then Active Cue</arm_group_label>
    <arm_group_label>Active Cue first, then Neutral Cue</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosis of nicotine dependence with psychological dependence

          -  Smokes at least 15 cigarettes per day for the three months prior to enrollment

          -  Currently not seeking treatment for nicotine dependence

          -  Medically healthy, on the basis of physical examination and medical history, vital
             signs, EKG, and laboratory tests

          -  Females must use an effective method of contraception for the duration of the study

        Exclusion Criteria:

          -  Diagnosis of abuse or dependence on alcohol or drugs other than nicotine

          -  Current Axis I diagnosis or current treatment with psychotropic medications within the
             3 months prior to enrollment

          -  History of schizophrenia or other psychotic disorders, bipolar disorder, or anxiety
             disorders

          -  Currently seeking treatment for nicotine disorders

          -  On parole or probation

          -  History of seizures or head trauma with loss of consciousness, brain contusion, or
             fracture

          -  History of significant recent violent behavior

          -  Blood pressure greater than 150/90

          -  History of eating disorders

          -  Pregnant
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Adam Bisaga, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>New York State Psychiatric Institute</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Columbia University</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10023</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 25, 2005</study_first_submitted>
  <study_first_submitted_qc>August 25, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 29, 2005</study_first_posted>
  <results_first_submitted>April 14, 2015</results_first_submitted>
  <results_first_submitted_qc>April 6, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">May 11, 2016</results_first_posted>
  <last_update_submitted>April 6, 2016</last_update_submitted>
  <last_update_submitted_qc>April 6, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 11, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>tobacco use</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tobacco Use Disorder</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Twelve participants were recruited through advertisements in local newspapers and flyers.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Neutral Cue First, Then Active Cue</title>
          <description>Participants receives two consecutive interventions in random order.
Neutral Cue: during this phase of treatment participants were presented with neutral (sham) cue
Cigarette cue: during this phase of treatment participants were presented with active cigarette cue</description>
        </group>
        <group group_id="P2">
          <title>Active Cue First, Then Neutral Cue</title>
          <description>Each participant receives two consecutive interventions in random order.
Cigarette cue: during this phase of treatment participants were presented with active cigarette cue
Neutral Cue: during this phase of treatment participants were presented with neutral (sham) cue</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>First Intervention ( 5 Days)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="6"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="6"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Second Intervention ( 5 Days)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="6"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="6"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Study Participants</title>
          <description>This is a within-group study design, all participant who completed the study completed 2 phases of treatment, done in random order, each lasting 5 days and separated by at least 2 weeks. During one of the phases participants were exposed to active cigarette cues (pack of cigarettes, smoke) and during the other phase they were exposed to sham control cues (water bottle and the glass)</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="12"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="31" spread="6.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>American Indian or Alaska Native</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Asian</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Native Hawaiian or Other Pacific Islander</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Black or African American</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>White</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>More than one race</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Unknown or Not Reported</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Cigarette Choice After 3 Day Abstinence</title>
        <description>Following 3 days of abstinence participants had an option to smoke cigarettes every 30 minutes for the maximum of 6 choices</description>
        <time_frame>During Day 4 experimental session</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Active Cue</title>
            <description>During this phase participants were exposed to active cigarette cues: pack of cigarettes and a cigarette smoke</description>
          </group>
          <group group_id="O2">
            <title>Neutral Cue</title>
            <description>During this phase of study participants were exposed to a neutral (sham) cue: a bottle of water and a glass</description>
          </group>
        </group_list>
        <measure>
          <title>Cigarette Choice After 3 Day Abstinence</title>
          <description>Following 3 days of abstinence participants had an option to smoke cigarettes every 30 minutes for the maximum of 6 choices</description>
          <units>number of cigarette choices (0-6)</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.50" spread="0.63"/>
                    <measurement group_id="O2" value="3.67" spread="0.58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Craving</title>
        <description>Measure of self-reported craving on a scale of 0-70 (0=no craving; 70= worst possible craving).</description>
        <time_frame>immediately following cue expose</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Active Cue Craving</title>
            <description>intensity of craving following cue exposure</description>
          </group>
          <group group_id="O2">
            <title>Neutral Cue Craving</title>
            <description>intensity of craving following cue exposure</description>
          </group>
        </group_list>
        <measure>
          <title>Craving</title>
          <description>Measure of self-reported craving on a scale of 0-70 (0=no craving; 70= worst possible craving).</description>
          <units>units on a scale (0-70)</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="12"/>
                <count group_id="O2" value="12"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="58.8" spread="3.1"/>
                    <measurement group_id="O2" value="53.8" spread="5.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>During the study</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Neutral Cue</title>
          <description>Neutral Cue: during this phase of treatment participants were presented with neutral (sham) cue</description>
        </group>
        <group group_id="E2">
          <title>Active Cue</title>
          <description>1.Cigarette cue: during this phase of treatment participants were presented with active cigarette cue.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="12"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="12"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Adam Bisaga</name_or_title>
      <organization>New York State Psychiatric Institute</organization>
      <phone>646-774-6155</phone>
      <email>bisagaa@nyspi.columbia.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

